TrialLancet (London, England)2011
Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial.
Paul D Griffiths et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
211 papers cite itlatest 60 shown
this paperpooled ittrialcites it